Used in clinical research and therapeutic development for inflammatory and autoimmune diseases. Targets interleukin-18 (IL-18), a pro-inflammatory cytokine involved in conditions like type 2 diabetes, rheumatoid arthritis, and certain skin disorders. By neutralizing IL-18 activity, it helps modulate immune response and reduce inflammation. Investigated in trials for its potential to improve metabolic function and control disease activity in patients with chronic inflammatory conditions. Also serves as a reference standard in immunoassays and bioanalytical testing during drug development.